SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001659617-19-000202
Filing Date
2019-12-23
Accepted
2019-12-23 16:11:08
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 a2019q4s-3dated12x23x2019.htm S-3 282174
2 EXHIBIT 4.1 exh41seniorindenture.htm EX-4.1 537430
3 EXHIBIT 4.2 exh42subordinatedindenture.htm EX-4.2 598667
4 EXHIBIT 5 exh5schiffopinion.htm EX-5 28191
5 EXHIBIT 23.1 exh231grantthornton.htm EX-23.1 4113
6 moleculin-logo.jpg GRAPHIC 132868
  Complete submission text file 0001659617-19-000202.txt   1623981
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-235686 | Film No.: 191306118
SIC: 2834 Pharmaceutical Preparations